TargetFish - an international collaboration involving theUniversityofAberdeen-brings together leading researchers fromEurope's biotech and veterinary sectors with the aim of commercialising fish vaccines for European fish farming.
European aquaculture production provides work for around 65,000 people and has a turnover of € 3 billion.
However infectious fish diseases can impact on plans to increase production and in some instances no effective treatments are available.
The best method for disease control - both on economical and ethical grounds - is disease prevention by vaccination.
Professor Chris Secombes, Chair of Zoology at theUniversityofAberdeen, is leadingAberdeen's involvement in the collaboration. He said: "TargetFish will advance the development of existing - but not sufficient - vaccines as well as new prototype ones which will target socio-economically important viral or bacterial pathogens of Atlantic salmon, rainbow trout, common carp, sea bass, seabream and turbot.
"TargetFish will also establish a knowledge and technology base for the development of next generation fish vaccines.
"This project will greatly enhance targeted disease prevention in European fish farming."
Provided by University of Aberdeen
This Phys.org Science News Wire page contains a press release issued by an organization mentioned above and is provided to you “as is” with little or no review from Phys.Org staff.